Transgender People: Immunity, Prevention, and Treatment (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-054 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 12, 2019 Category: Research Source Type: funding
PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)
Funding Opportunity RFA-DA-20-013 from the NIH Guide for Grants and Contracts. NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the e...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 16, 2019 Category: Research Source Type: funding
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. This opportunity is specifically designed to promote partnerships between eligible NIH Intramural Research Program (IRP) investigators (e.g. those conducting research within the labor...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 4, 2019 Category: Research Source Type: funding
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
Funding Opportunity PA-19-096 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research to advance the understanding of natural history of infection for three sexually transmitted infections (STIs): gonorrhea, syphilis, and chlamydia. This research opportunity encourages studies that address the natural history of infection in the context of either: 1) correlates of protection, 2) host response to infection, 3) clinical endpoints of disease, or 4) biological and clinical factors that influence clearance rather than persistence of infection. (Source: ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 29, 2018 Category: Research Source Type: funding
Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-046 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine Treatment and Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding
Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-047 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to form a Leadership Group for an Infectious Diseases Clinical Research Consortium, hereafter referred to as the Leadership Group (LG), to support the planning and implementation of clinical research that addresses the scientific priorities of NIAID in evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases. A companion FOA sol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-18-005 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications for the Sexually Transmitted Infections Cooperative Research Centers (STI CRC) program. This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum. In addition, the F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 16, 2018 Category: Research Source Type: funding
Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S.-Affiliated Pacific Islands
Grants for integrated HIV, VH, STD, and TB prevention and treatment services at the client level, through enhanced collaboration at the jurisdiction and organizational program levels, specifically improving the collection, reporting, use, and sharing of surveillance data for HIV, VH, STD, and TB prevention. Geographic coverage: U.S.-Affiliated Pacific Islands -- Centers for Disease Control and Prevention, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 2, 2017 Category: American Health Source Type: funding
Community Approaches to Reducing Sexually Transmitted Diseases (CARS)
Funding Opportunity ID: 290103 Opportunity Number: CDC-RFA-PS17-1707 Opportunity Title: Community Approaches to Reducing Sexually Transmitted Diseases (CARS)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.978Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: Agency Code: HHS-CDC-NCHHSTPAgency Name: Departmen...
Source: Grants.gov - March 30, 2017 Category: Research Tags: Health Source Type: funding
Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)
Funding Opportunity ID: 292838 Opportunity Number: CDC-RFA-CK13-1301 Opportunity Title: Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.099Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Pan American Health Organizati...
Source: Grants.gov - March 29, 2017 Category: Research Tags: Health Source Type: funding
Enhancing national STD/HIV prevention efforts by promoting holistic, comprehensive, and evidence-informed health and wellness approaches through strategic partnerships
Funding Opportunity ID: 292558 Opportunity Number: CDC-RFA-PS17-1708 Opportunity Title: Enhancing national STD/HIV prevention efforts by promoting holistic, comprehensive, and evidence-informed health and wellness approaches through strategic partnershipsOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.978Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligib...
Source: Grants.gov - March 18, 2017 Category: Research Tags: Health Source Type: funding
FY17 - FY18 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries
Funding Opportunity ID: 290364 Opportunity Number: N00244-17-S-FO01 Opportunity Title: FY17 - FY18 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AIDS Relief) Funded CountriesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 12.350Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additio...
Source: Grants.gov - February 21, 2017 Category: Research Tags: Health Source Type: funding
FY17 - FY18 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AID Relief) Funded Countries
Funding Opportunity ID: 290111 Opportunity Number: N00244-17-S-FO02 Opportunity Title: FY17 - FY18 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AID Relief) Funded CountriesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 12.350Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional I...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding
